2017 American Transplant Congress
Does Simultaneous Liver Kidney Transplant in Patients with MELD ≥35 on Renal Replacement Therapy at the Time of Transplant Improve Outcome?
Transplant Hepatology, Univ. of Tennessee, Memphis, TN
Background: A significant proportion of patients with MELD ≥35 have renal failure requiring renal replacement therapy (RRT) at the time of transplant, and receive either…2017 American Transplant Congress
The Effect of Transplant Center Volume on Survival Outcomes for Patients Listed for Simultaneous Liver and Kidney Transplantation.
This study examines the effect of center volume on survival differences between Simultaneous Liver Kidney Transplantation (SLKT) and liver transplantation alone (LTA).Methods: The United Network…2017 American Transplant Congress
Patient Outcomes Following the Disappearance of Donor Specific Antibody in Crossmatch Positive Simultaneous Liver-Kidney Transplant Recipients.
Background: Simultaneous liver and kidney transplantation (SLKT) remains as the gold standard for patients with chronic renal and liver diseases. Pre-transplant donor-specific antibody (DSA) to…2017 American Transplant Congress
A UNOS Database Analysis of Patient Outcomes from Kidney Alone versus Simultaneous Kidney Liver Transplants Utilizing Matched Donor Pairs.
Surgery - Division of Transplantation, University of Wisconsin - Madison, Madison, WI
Introduction: Renal grafts used in simultaneous kidney liver (SLK) transplants are allocated by arbitrary clinical criteria without entering the kidney allocation algorithm. The goal of…2017 American Transplant Congress
An Argument for Expanding the Simultaneous Liver and Kidney Transplant Criteria: Validity of the New UNOS Allocation Policy.
Aim: According to the latest simultaneous liver-kidney transplant (SLK) allocation policy by UNOS, allocation of kidney is dependent on duration of low glomerular filtration rate…2017 American Transplant Congress
Simultaneous Liver-Kidney Transplants Using Donation After Cardiac Death Donors Long Term Outcomes Not Inferior to Brain Dead Donors.
University of Maryland School of Medicine, Baltimore, MD
Background:The Simultaneous use of both Liver and Kidney from the same DCD donor has become controversial with some authors advocating that DCD organs should not…2017 American Transplant Congress
Combined Dual-Kidney Liver Transplantation in the United States: A Review of UNOS/OPTN Data Between 2002 and 2012.
Department of Medicine, UCLA, Los Angeles, CA
BackgroundSimultaneous liver-kidney transplantation (SLKT) has increased demand for donor kidneys during a national organ shortage. In kidney-alone recipients, dual kidney transplantation (DKT) using “marginal” donor…2017 American Transplant Congress
Benefit of Anti-Hepatitis B Immunoglobulin(HBIG) Monotherapy Compared to HBIG Combined with Entecavir in Long Term Renal Function.
Background: To reduce the HBV reinfection after liver transplantation, anti-hepatitis B immunoglobulin (HBIG) alone or combination with antiviral nucleotide analogues are usually used regimen. However,…2017 American Transplant Congress
Incidence and Outcomes of Immediate Post-Operative Dialysis in Liver Transplantation.
Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI
Aim: Although kidney dysfunction secondary to hepatorenal syndrome is expected to recover with liver transplant alone (LTA), patients with pre-transplant marginal kidney function may be…2017 American Transplant Congress
The Impact of De Novo Post-Transplant Diabetes on Hepatic Steatosis and Liver Transplant Outcomes.
Introduction: As the prevalence of diabetes (DM) increases in the general population, it is also increasing in the transplant (Tx) population. Post-transplant diabetes (PTDM) has…
American Transplant Congress abstracts